FOLH1 and prostate cancer: Our inability to express hPSMA in the mouse prostate may reflect the inability of the normal prostate to tolerate high levels of PSMA, in contrast to prostate cancer, a phenomenon worthy of further study to potentially reveal a novel vulnerability in prostate cancer.